Renalytix Plc (RENX.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.49M |
| Enterprise Value | 16.81M |
| P/E Ratio | -3.38 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 30.04 |
| Price/Book Ratio | -22.85 |
| Enterprise/Revenue | 29.85 |
| Enterprise/EBITDA | 0 |
Fiscal Year
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -5.06 |
| Operating Margin | -4.44 |
AD
Management Effectiveness
| Return On Assets | -0.82 |
| Return On Equity | 6.75 |
Income Statement
| Revenue | 3.01M |
| Revenue/Share | 0 |
| Gross Profit | 1.1M |
| EBITDA | -13.83M |
| Net Income | -14.24M |
| Diluted EPS | -0.03 |
Balance Sheet
| Total Cash | 6.2M |
| Total Cash/Share | 0.02 |
| Total Debt | 5.8M |
| Total Debt/Equity | -4.83 |
| Current Ratio | 1.57 |
| Book Value Per Share | -0 |
Price History
| 52-Week Change | -25.52 |
| 52-Week High | 7.63 |
| 52-Week Low | 1.6 |
| Moving Average 50 Days | 5.63 |
| Moving Average 200 Days | 3.45 |
Statistics
| Average Volume | 1.32M |
| Shares Outstanding | 670.46M |
| % Held by Institutions | 0.24 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
